![Alexandra Dietrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexandra Dietrich
Directeur Général chez Syntacoll Gmbh
Provenance du réseau au premier degré de Alexandra Dietrich
Entité | Type d'entité | Industrie | |
---|---|---|---|
Syntacoll Gmbh
![]() Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Alexandra Dietrich via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ABZENA PLC | Biotechnology | President | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree | |
VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Abzena Holdings Us LLC | President | ||
INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Chief Executive Officer |
Statistiques
Internationale
Etats-Unis | 6 |
Royaume-Uni | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Opérationnelle
President | 3 |
Director/Board Member | 2 |
Chief Operating Officer | 2 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Relations les plus connectées
Insiders | |
---|---|
Kimball Hall | 7 |
- Bourse
- Insiders
- Alexandra Dietrich
- Connexions Sociétés